Zealand Pharma A/S (CPH:ZEAL)
209.80
-2.90 (-1.36%)
Nov 20, 2026, 5:00 PM CET
Zealand Pharma Employees
Zealand Pharma had 605 employees as of September 30, 2026. The number of employees increased by 165 or 37.50% compared to the same quarter last year. That makes Zealand Pharma the 18,583rd largest employer in the world and 55th in Denmark.
Employees
605
Change (1Y)
165
Growth (1Y)
37.50%
Revenue / Employee
7.60M DKK
Profits / Employee
5.11M DKK
Market Cap
14.02B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2026 | 605 | 165 | 37.50% | 605 | 0 |
| Jun 30, 2026 | 578 | 154 | 36.32% | 578 | 0 |
| Mar 31, 2026 | 544 | 159 | 41.30% | 544 | 0 |
| Dec 31, 2025 | 501 | 146 | 41.13% | 481 | 20 |
| Sep 30, 2025 | 440 | 142 | 47.65% | 440 | 0 |
| Jun 30, 2025 | 424 | 136 | 47.22% | 424 | 0 |
| Mar 31, 2025 | 385 | 115 | 42.59% | 385 | 0 |
| Dec 31, 2024 | 355 | 102 | 40.32% | 335 | 20 |
| Sep 30, 2024 | 298 | 49 | 19.68% | 298 | 0 |
| Jun 30, 2024 | 288 | 52 | 22.03% | 288 | 0 |
| Mar 31, 2024 | 270 | 50 | 22.73% | 270 | 0 |
| Dec 31, 2023 | 253 | 57 | 29.08% | 253 | 0 |
| Sep 30, 2023 | 249 | 46 | 22.66% | 249 | 0 |
| Jun 30, 2023 | 236 | -1 | -0.42% | 236 | 0 |
| Mar 31, 2023 | 220 | -125 | -36.23% | 220 | 0 |
| Dec 31, 2022 | 196 | -159 | -44.79% | 196 | 0 |
| Sep 30, 2022 | 203 | -143 | -41.33% | 203 | 0 |
| Jun 30, 2022 | 237 | -98 | -29.25% | 237 | 0 |
| Mar 31, 2022 | 345 | 10 | 2.99% | 345 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 66,700 |
| Demant | 26,616 |
| Coloplast | 17,270 |
| GN Store Nord | 7,856 |
| Ambu A/S | 4,664 |
| Embla Medical | 4,500 |
| Genmab | 3,244 |
| ALK-Abelló | 2,773 |
Zealand Pharma News
- 4 days ago - Zealand Pharma initiates ZYNERGY trial - TheFly
- 6 days ago - Zealand Pharma Transcript: Jefferies Global Healthcare Conference - Transcripts
- 9 days ago - Zealand Pharma announces EU approval of Zeydovio for SBS - TheFly
- 10 days ago - Zealand Pharma Earnings Call Transcript: Q3 2026 - Transcripts
- 10 days ago - Zealand Pharma Quarterly report: Q3 2026 - Filings
- 10 days ago - Zealand Pharma Slides: Q3 2026 - Filings
- 13 days ago - Boehringer, Zealand's obesity drug did not raise heart risks in trial, data shows - Reuters
- 13 days ago - Zealand Pharma says Boehringer Ingelheim Phase 3 trial met primary endpoint - TheFly